Use of psychosocial services by lung cancer survivors in Germany : Results of a German multicenter study (LARIS).

Nutzung psychosozialer Angebote bei Lungenkrebsüberlebenden in Deutschland : Ergebnisse einer deutschen Multizenterstudie (LARIS).

Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 01 03 2019
accepted: 22 06 2019
pubmed: 12 7 2019
medline: 20 3 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

Little is known about the use of psychosocial services in lung cancer survivors and patients who have survived the diagnosis for at least one year. We investigated the frequency of use, stratified by radiation therapy received, its associated factors, and the reasons for non-use of those services. We performed a multicenter (n = 6 hospitals) cross-sectional study using data from medical records, patient reported questionnaires, and computer-assisted telephone interviews. Odds ratios (OR) for factors potentially associated with the use of any type of psychosocial services were calculated using multivariable logistic regression. We included 604 lung cancer patients/survivors. Of them, 60% (69% of those who had received radiotherapy) had used some kind of psychological and/or social service in the past (47% psychological, 42% social); 39% had used inpatient care, 24% outpatient care (cancer counselling center, general counselling center, psychological counselling by family doctor, psychotherapy, patient support group, pastoral work). Of those who visited a rehabilitation clinic, 66% received psychosocial care there. Factors associated with using psychosocial services in general were female gender (OR 1.96, 95% CI 1.32-2.93), poor emotional functioning (per unit decrease: OR 0.99, 95% CI 0.98-0.996), and younger age (per year decrease: OR 0.95, 95% CI 0.93-0.97). The high proportion of psychosocial care users among lung cancer survivors in Germany indicates that patients are interested in using it and that an unmet need exists. The creation of a broad spectrum of easily accessible services with high quality is important to enable and facilitate use.

Identifiants

pubmed: 31292665
doi: 10.1007/s00066-019-01490-1
pii: 10.1007/s00066-019-01490-1
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1018-1027

Références

J Clin Epidemiol. 2005 Nov;58(11):1090-100
pubmed: 16223651
Korean J Fam Med. 2016 Jul;37(4):228-34
pubmed: 27468341
Strahlenther Onkol. 2018 Jul;194(7):655-663
pubmed: 29532098
Psychother Psychosom Med Psychol. 2015 May;65(5):177-82
pubmed: 25485601
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12588
pubmed: 27734541
Strahlenther Onkol. 2017 Sep;193(9):763-764
pubmed: 28698902
BMC Med. 2017 Jan 13;15(1):10
pubmed: 28081724
Soc Psychiatry Psychiatr Epidemiol. 2017 Aug;52(8):1005-1013
pubmed: 28456871
Lung Cancer. 2007 Feb;55(2):215-24
pubmed: 17084483
Psychooncology. 2018 Dec;27(12):2847-2854
pubmed: 30276915
Psychother Psychosom Med Psychol. 2015 Dec;65(12):450-8
pubmed: 26200246
Lung Cancer. 2005 Nov;50(2):163-76
pubmed: 16137786
J Clin Oncol. 2010 Jun 20;28(18):3084-9
pubmed: 20479397
Arch Intern Med. 2000 Jul 24;160(14):2101-7
pubmed: 10904452
Psychooncology. 2017 Aug;26(8):1093-1098
pubmed: 28317215
J Thorac Oncol. 2019 Mar;14(3):420-435
pubmed: 30508641
Psychooncology. 2013 Oct;22(10):2160-8
pubmed: 23097417
Strahlenther Onkol. 2017 Jul;193(7):595-597
pubmed: 28516198
J Clin Oncol. 2002 Jul 1;20(13):2920-9
pubmed: 12089220
J Clin Oncol. 2000 Feb;18(4):893-903
pubmed: 10673533
Psychooncology. 2018 Aug;27(8):2002-2008
pubmed: 29761591
Cancer. 2001 Nov 15;92(10):2609-22
pubmed: 11745196
Qual Life Res. 1994 Apr;3(2):127-41
pubmed: 8044158
Lung Cancer (Auckl). 2017 Jul 28;8:79-90
pubmed: 28814906
Z Psychosom Med Psychother. 2000 Mar;46(1):4-17
pubmed: 11793301
Int Stat Rev. 2010 Apr;78(1):40-64
pubmed: 21743766
Dtsch Med Wochenschr. 2007 Oct;132(40):2071-6
pubmed: 17899501
Clin Lung Cancer. 2017 Sep;18(5):497-503
pubmed: 28412094

Auteurs

Martin Eichler (M)

Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany. martin.eichler@uniklinikum-dresden.de.
German Cancer Consortium (DKTK), Heidelberg, Germany. martin.eichler@uniklinikum-dresden.de.
Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany. martin.eichler@uniklinikum-dresden.de.

Marlene Hechtner (M)

Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Beatrice Wehler (B)

Department of Radio-Oncology, University Hospital Saarland, Homburg, Germany.
Department of Hematology, Medical Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.

Roland Buhl (R)

Department of Hematology, Medical Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.

Jan Stratmann (J)

Medical Department II, University Hospital Frankfurt, Frankfurt, Germany.

Martin Sebastian (M)

Medical Department II, University Hospital Frankfurt, Frankfurt, Germany.

Heinz Schmidberger (H)

Department of Radio-Oncology, University Medical Center Mainz, Mainz, Germany.

Cornelius Kortsik (C)

Department of Pulmonology, Hildegardis Hospital, Mainz, Germany.

Ursula Nestle (U)

Department of Radiation Oncology, University Medical Center, Freiburg, Germany.
Department of Radiotherapy, Kliniken Maria Hilf, Moenchengladbach, Germany.

Hubert Wirtz (H)

Department of Pneumology, University Medical Centre Leipzig, Leipzig, Germany.

Thomas Wehler (T)

Department of Internal Medicine V, University Hospital Saarland, Homburg, Germany.

Maria Blettner (M)

Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.

Susanne Singer (S)

Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH